Maven Securities LTD Repligen Corp Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $2.17 Million - $2.67 Million	-8,773 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $852,897 - $1.42 Million	-4,379 Reduced 33.3%	8,773 $2.54 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $2.18 Million - $2.91 Million	13,152 New	13,152 $2.65 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $4.51 Million - $5.66 Million	-25,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $3.7 Million - $5.16 Million	25,000 New	25,000 $4.79 Million

495

53.9M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.26B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.